mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.8 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |